ALLMedicine Early Pregnancy Loss Center

May 27th, 2020 - Periostin is secreted from the placenta in the embryonic period and it is emphasized that it may be involved in endometrial implantation. In this study, we aimed to investigate periostin serum levels and placental tissue expression in first trimes...

May 17th, 2020 - The majority of early pregnancy losses are due to chromosomal abnormalities, which can be evaluated by testing the products of conception (POCs). Traditionally, a dilation and curettage (D&C) is recommended to patients to obtain suitable tissue fo...

May 13th, 2020 - Abortion and miscarriage are common, affecting millions of US women each year. By age 45, one in four women in the USA will have had an abortion, and at least as many will have had a miscarriage. Most individuals seeking abortion services do so be...

May 8th, 2020 - Can maternal plasma cell-free DNA (cfDNA) detect chromosomal anomalies in early pregnancy loss (EPL) and recurrent pregnancy loss (RPL)? Genome-wide cfDNA testing can serve as an alternative to cytogenetic analysis in products of conception (POCs)...

Apr 19th, 2020 - Early pregnancy loss is a common event in the first trimester, occurring in 15%-20% of confirmed pregnancies. A common evidence-based medical regimen for early pregnancy loss uses misoprostol, a prostaglandin E1 analog, with a dosage of 800 μg, se...

Dec 30th, 2018 - Medical abortion care encompasses the management of various clinical conditions including spontaneous and induced abortion (both viable and non-viable pregnancies), incomplete abortion and intrauterine fetal demise, as well as post-abortion contra.

Aug 29th, 2018 - Early pregnancy loss, or loss of an intrauterine pregnancy within the first trimester, is encountered commonly in clinical practice. Obstetricians and gynecologists should understand the use of various diagnostic tools to differentiate between via...

May 1st, 2015 - Early pregnancy loss, or loss of an intrauterine pregnancy within the first trimester, is encountered commonly in clinical practice. Obstetricians and gynecologists should understand the use of various diagnostic tools to differentiate between via...

May 27th, 2020 - Periostin is secreted from the placenta in the embryonic period and it is emphasized that it may be involved in endometrial implantation. In this study, we aimed to investigate periostin serum levels and placental tissue expression in first trimes...

May 17th, 2020 - The majority of early pregnancy losses are due to chromosomal abnormalities, which can be evaluated by testing the products of conception (POCs). Traditionally, a dilation and curettage (D&C) is recommended to patients to obtain suitable tissue fo...

May 13th, 2020 - Abortion and miscarriage are common, affecting millions of US women each year. By age 45, one in four women in the USA will have had an abortion, and at least as many will have had a miscarriage. Most individuals seeking abortion services do so be...

May 8th, 2020 - Can maternal plasma cell-free DNA (cfDNA) detect chromosomal anomalies in early pregnancy loss (EPL) and recurrent pregnancy loss (RPL)? Genome-wide cfDNA testing can serve as an alternative to cytogenetic analysis in products of conception (POCs)...

Apr 19th, 2020 - Early pregnancy loss is a common event in the first trimester, occurring in 15%-20% of confirmed pregnancies. A common evidence-based medical regimen for early pregnancy loss uses misoprostol, a prostaglandin E1 analog, with a dosage of 800 μg, se...

Feb 6th, 2020 - Women who have experienced early pregnancy loss may experience clinically significant posttraumatic stress, anxiety, and depression 9 months after the loss, new research suggests. AkilinaWinner/Thinkstock The outcomes of a prospective cohort study.

Jan 20th, 2020 - Women experienced moderate to severe depression, moderate to severe anxiety, or posttraumatic stress a month following early pregnancy loss from miscarriage or ectopic pregnancy, and for some patients, these stress-related conditions persisted at ...

Dec 9th, 2019 - CHALLENGES TO IMPLEMENTATION FDA restrictions limit availability of mifepristone The main challenge to implementation is the availability of mifepristone. Mifepristone was approved by the US Food and Drug Administration in 2000.

Aug 6th, 2019 - Complications and intervention Major complications are rare with medical management of first-trimester abortion and early pregnancy loss, but can include ongoing pregnancy, which is infrequent but possible; incomplete abortion, which is easily man.

Apr 8th, 2019 - Nicotine and Infertility The success or failure of assisted reproduction can be influenced by many factors, both nonmodifiable (age, ovarian reserve) and modifiable (body weight, lifestyle habits). Smoking belongs to the latter category. Smoking h...